Dr. Gwyn Humphreys
Non-executive Chairman
Gwyn was appointed Chairman of Avacta in December 2005. Gwyn has extensive experience of technology transfer and early-stage technology companies. Originally a biochemist/molecular biologist, Gwyn spent ten years in academic research, followed by ten years at Celltech Limited where, for three years, he was responsible for creating and managing a joint-venture company (Apcel) with Air Products. In 1995 Gwyn was a founder and Managing Director of Bradford Particle Design plc which was sold in 2001 to Nektar Therapeutics Inc. Gwyn is also Non-executive Director of Syntopix Group plc.